Skip to content

Ethically Accepted With Code 851/2971 A Comparison of Class Ⅱ Malocclusion Treatment Using Van Beek-headgear Activator Versus Andresen Activator

A Comparison of Class Ⅱ Malocclusion Treatment Using Van Beek-headgear Activator Versus Andresen Activator: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05604625
Enrollment
24
Registered
2022-11-03
Start date
2022-12-15
Completion date
2023-06-15
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Class II Growth Modification

Brief summary

The aim of this study is to compare the treatment results when treating Class II division 1 malocclusion using the Van Beek-Headgear Activator combination (vBHGA) appliance versus using the Andresen activator.

Interventions

DEVICEVan-Beek activator and a headgear

12 patients will receive Van-Beek activator and a headgear

DEVICEAndresen activator

12 patients will receive Andresen activator.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Class II division 1 indicated by ANB angle value ≥ 4º * Class II division 1 with overjet \> 5mm. * An age range between 8 and 13 years growing patient using cervical vertebral stage assessment (CVS). * No previous orthodontic treatment * No indications or symptoms of periodontal disease in the past or present, as determined by clinical and radiographic examination

Exclusion criteria

* Missing teeth (excluding 3rd molars). * Craniofacial anomalies. * Medical condition or prescription medication that may affect growth. * Lack of compliance whenever documented in the charts.

Design outcomes

Primary

MeasureTime frameDescription
treating Class II division 1 malocclusionat 8 monthsrate of mandibular and maxillary growth

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026